 | |
PPD Headquarters in Wilmington, NC
| |
| Company type | Subsidiary |
|---|---|
| Industry | Contract research organizations Pharmaceutical Biotechnology |
| Founded | 1985 |
| Headquarters | Waltham, Massachusetts, United States |
Key people | See Senior Leadership Team page of the PPD Website[1] |
| Products | Contract clinical research for pharmaceutical, biotechnology, medical device, academic and government organizations; services include drug development, laboratory and lifecycle management. |
| Revenue |  $4.7 Billion (2020)[2] |
Number of employees | 40,000+ (2023) |
| Parent | Thermo Fisher Scientific |
| Website | https://www.ppd.com |
Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services. In December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific.
PPD was founded by Fred Eshelman, Pharm.D., as a one-person consulting firm in 1985. The following year, he expanded the company's scope to include development services and relocated operations from Maryland to North Carolina.
PPD has its headquarters in Wilmington, North Carolina. The company has more than 27,000 employees. As of December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific, based in Waltham, Massachusetts.
|
| |
|---|---|
| Clinical Research |
|
| Clinical and Healthcare IT |
|
| Manufacturing |
|
